peptide powder Adipotide 2mg for Weight Loss peptides FTTP
Product description
| Product name |
Adipotide |
| CAS No. |
N/A |
| Molecular Formula |
C62H98N16O22 |
| Molecular weight |
1419.53552 |
| Grade Standard |
Medicine Grade |
| COA |
Avaliable |
| Specification |
2mg/vial |
Physical Characters and specifications
| Item |
Specifications |
| Appearance |
White powder. |
| Purity |
99%min |
| Boiling point |
1802.9±65.0ºC at 760 mmHg |
| Density |
1.4±0.1 g/cm3 |
| Refractive index |
1.576 |
| Flash point |
1044.2±34.3ºC |
| Storage condition |
2-8ºC |
| Shelf life |
2 years |
Adipotide is a new drug that is showing some promise in the area of obesity research. This drug was initially created as a cancer treatment designed to starve cancer cells of a blood supply so they would stop growing. The effects of Adipotide have shown that the drug actually starves fat cells of blood forcing them to die and be reabsorbed into the body. Initial tests were done on rats and then moved on to monkeys. The results from testing on rats showed a 30 percent decrease in body weight. After four weeks of daily injections of Adipotide followed by four weeks of non-treatment, 10 obese female rhesus monkeys lost an average of 11 percent of their body weight and 39 percent of fat deposits. Most of the loss was experienced during the non-treatment period.
Function
Adipotide, a peptidomimetic with sequence CKGGRAKDC-GG-D(KLAKLAK)2, is an experimental proapoptotic drug that has been shown to cause rapid weight loss in mice and rhesus monkeys. Its mechanism of action is to target specific blood vessels supplying adipose tissue with blood, cause the vessels to shrink and the fat cells fed by those vessels to undergo apoptosis.Adipotide is designed to bind to two receptors, ANXA2 and prohibitin, that are specific to blood vessels supplying white adipose tissue.
){kind=link}